Next |
home / stock / mlnd / mlnd message board
Subject | By | Source | When |
---|---|---|---|
Looking good so far... | Eurotradr | investorshub | 06/24/2021 1:40:50 PM |
Adding here for the bounce. | Eurotradr | investorshub | 06/24/2021 1:37:50 PM |
Sitting in an oversold position. Let's see the | Eurotradr | investorshub | 06/24/2021 1:37:10 PM |
Time for a reversal and bounce off the | Eurotradr | investorshub | 06/23/2021 1:09:14 PM |
Something really could happen here soon. Course will | Schnatzi | investorshub | 05/04/2021 2:03:03 PM |
What's going on here? Chart looks good and | Schnatzi | investorshub | 04/08/2021 6:41:42 AM |
new support level and rising even on lower | PitBull2 | investorshub | 02/12/2021 9:16:31 PM |
Perfect. Might even fill down gap at 4.85 | MoneyMan | investorshub | 02/10/2021 2:44:50 PM |
Chart is looking good, breaking $2.30's and it | MoneyMan | investorshub | 02/05/2021 4:23:50 PM |
Great R/M candidate trading under cash now. | MoneyMan | investorshub | 01/24/2021 2:03:39 PM |
$MLND chugging! $CEO Bio below. | Werbe | investorshub | 01/13/2021 5:21:44 PM |
They breakout the M/A news here, gonna hit | Werbe | investorshub | 01/11/2021 6:19:45 PM |
MLE-301 is now dead. PPS seems to | Werbe | investorshub | 01/08/2021 5:18:57 PM |
3 research operations killed now. SVB Leerink | Werbe | investorshub | 01/07/2021 9:00:44 PM |
Back in for 4000 @ $2.04 Wait and see. | swingingRichard | investorshub | 12/11/2020 8:31:29 PM |
well. it's october and while there has been | swingingRichard | investorshub | 10/02/2020 3:29:41 AM |
if it could ever get into the gap. | makingitnow | investorshub | 08/28/2020 2:19:33 AM |
I'mma hanging in. | swingingRichard | investorshub | 08/28/2020 1:31:15 AM |
I am not feeling it. if it were | makingitnow | investorshub | 08/27/2020 8:42:05 PM |
$3 or above by October. | swingingRichard | investorshub | 07/24/2020 9:56:06 PM |
News, Short Squeeze, Breakout and More Instantly...
Millendo Therapeutics Company Name:
MLND Stock Symbol:
NASDAQ Market:
SOUTH SAN FRANCISCO, Calif. and ANN ARBOR, Mich., June 22, 2021 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (“Tempest”), a clinical-stage oncology company developing potentially first-in-class therapeutics that combine both targeted and immune-mediated mechanisms, and Mille...
Shares of Millendo Therapeutics Inc. (NASDAQ:MLND) traded today at $0.93, breaking its 52-week low. So far today approximately 1.6 million shares have been exchanged, as compared to an average 30-day volume of 1 million shares. Over the past year, Millendo Therapeutics Inc. has traded in...
Shares of Millendo Therapeutics Inc. (NASDAQ:MLND) traded today at $0.97, breaking its 52-week low. So far today approximately 1.6 million shares have been exchanged, as compared to an average 30-day volume of 1 million shares. Millendo Therapeutics Inc is a late-stage biopharmaceutical ...